ILMN
Illumina, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$217.37
−1.94%Leverage
- Debt / equity
- 0.89x
- Net debt / equity
- 0.52x
- Debt / assets
- 0.38x
- Debt / EBITDA
- 1.85x
- Net debt / EBITDA
- 1.09x
Liquidity & coverage
- Current ratio
- 1.80x
- Quick ratio
- 1.40x
- Cash ratio
- 0.74x
- Interest coverage
- 12.56x
- EBITDA / interest
- 18.17x
- Working capital
- $1.3B
Cash & dividend
- FCF / debt
- 0.37x
- Cash flow / debt
- 0.43x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026